EDGAR Filing Documents for 0001144204-17-052845

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001144204-17-052845

Filing Date

2017-10-17

Accepted

2017-10-17 16:42:57

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tv476792_424b5.htm	424B5	1252890
2	GRAPHIC	tv476792_img1.jpg	GRAPHIC	18296
3	GRAPHIC	tv476792_img2.jpg	GRAPHIC	8768
	Complete submission text file	0001144204-17-052845.txt		1291616

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B5 | Act: 33 | File No.: 333-198107 | Film No.: 171141035
SIC: 2834 Pharmaceutical Preparations